Process for the preparation of a bioavailable oral dosage form of cefuroxime axetil
Patent 6346530 Issued on February 12, 2002. Estimated Expiration Date: 
August 4, 2019. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.
August 4, 2019. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.Patent ReferencesCephalosporin antibiotics Pharmaceutical composition comprising cefuroxime axetil R-cefuroxime axetil Methods for the manufacture of amorphous cefuroxime axetil Process for the preparation of cefuroxime axetil in an amorphous form Patent #: 6060599 InventorsApplicationNo. 366986 filed on 08/04/1999US Classes:514/226.81,3-ThiazinesExaminersPrimary: Jarvis, William R. A.Assistant: Kim, Vickie Attorney, Agent or FirmInternational ClassA61K 031/54Foreign Application Priority Data1999-03-19 INAbstractThis invention relates to a process of mixing of crystalline cefuroxime axetil with amorphous cefuroxime axetil for the preparation of a bioavailable oral dosage form comprising of amorphous cefuroxime axetil containing from 7 to 25% crystalline cefuroxime axetil.Other References
Field of Search1,3-Thiazines | |
